Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 330.00
Bid: 330.00
Ask: 331.50
Change: 2.00 (0.61%)
Spread: 1.50 (0.455%)
Open: 335.00
High: 351.00
Low: 327.50
Prev. Close: 328.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block listing Return

1 Jul 2020 15:44

RNS Number : 7603R
Oxford Biomedica PLC
01 July 2020
 

For Immediate Release

01 July 2020

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

01Jan 2020

To:

30 June 2020

Balance of unallotted securities under scheme(s) from previous return:

10,856

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

200,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

37,842

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

173,014

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

01Jan 2020

To:

30 June 2020

Balance of unallotted securities under scheme(s) from previous return:

270,875

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

59,136

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

211,739

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

01Jan 2020

To:

30 June 2020

Balance of unallotted securities under scheme(s) from previous return:

102,346

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

16,702

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

85,644

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

01Jan 2020

To:

30 June 2020

Balance of unallotted securities under scheme(s) from previous return:

159,044

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

200,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

66,864

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

292,180

 

 

 

Name of contact:

Natalie Walter

Telephone number of contact:

01865 783000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRRBMITMTIMBTM
Date   Source Headline
23rd Apr 20208:38 amRNSHolding(s) in Company
22nd Apr 202012:03 pmRNSKymriah receives FDA RMAT designation in FL
20th Apr 20204:49 pmRNSHolding(s) in Company
16th Apr 20203:17 pmRNSNotice of Results Update
8th Apr 20207:00 amRNSOxford Biomedica joins COVID-19 vaccine Consortium
1st Apr 20209:31 amRNSTotal Voting Rights
25th Mar 20201:06 pmRNSDirector Dealings / Market Share Purchase
20th Mar 20209:56 amRNSDirector/PDMR Shareholding
18th Mar 20207:00 amRNSOxford Biomedica Business Update
18th Mar 20207:00 amRNSLicense & Supply Agreement with Juno Therapeutics
2nd Mar 20209:22 amRNSTotal Voting Rights
26th Feb 20205:55 pmRNSDirector Dealings / Market Share Purchase
3rd Feb 20205:04 pmRNSClass 2 Transaction Announcement
3rd Feb 202011:56 amRNSTotal Voting Rights
3rd Feb 202011:55 amRNSDirector Dealings / Market Share Purchase
22nd Jan 202012:11 pmRNSBlock listing Application
7th Jan 202010:17 amRNSBlock Listing Return
2nd Jan 202011:41 amRNSTotal Voting Rights
19th Dec 20193:27 pmRNSDirector Dealings / Market Share Purchase
19th Dec 20197:00 amRNSExtension of Commercial Supply Agreement
2nd Dec 20199:31 amRNSTotal Voting Rights
27th Nov 201910:05 amRNSDirector Dealings / Market Share Purchase
13th Nov 20194:41 pmRNSHolding(s) in Company
1st Nov 20199:25 amRNSTotal Voting Rights
28th Oct 201912:30 pmRNSDirector Dealings / Market Share Purchase
23rd Oct 20197:00 amRNSHolding(s) in Company
23rd Oct 20197:00 amRNSHolding(s) in Company
16th Oct 20197:30 amEQSHardman & Co Research: Oxford BioMedica (OXB): Demanding second half
1st Oct 201910:18 amRNSTotal Voting Rights
25th Sep 201911:41 amRNSDirector Dealings / Market Share Purchase
16th Sep 201911:18 amRNSDirector/PDMR Shareholding
16th Sep 20199:15 amRNSDirectors Dealings / Market Share Purchases
13th Sep 20192:57 pmRNSLong Term Incentive Plan Option Grant
13th Sep 20191:13 pmRNSDirectors Dealings / Market Share Purchases
13th Sep 201910:53 amRNSDirector Dealings / Market Share Purchase
4th Sep 20197:00 amRNSOxford Biomedica Interim Results
2nd Sep 20199:31 amRNSTotal Voting Rights
23rd Aug 201911:06 amRNSDirector Dealings / Market Share Purchase
9th Aug 201912:00 pmRNSNotice of Interim Results
1st Aug 20199:18 amRNSTotal Voting Rights
25th Jul 20192:17 pmRNSDirector Dealings / Market Share Purchase
1st Jul 201911:04 amEQSHardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value
1st Jul 201910:01 amRNSBlock listing Interim Review
1st Jul 20199:32 amRNSTotal Voting Rights
28th Jun 20197:00 amRNSRepayment of Debt Facility
26th Jun 20192:52 pmRNSDirector Dealings / Market Share Purchase
26th Jun 20197:00 amRNSOXB and Santen enter R&D collaboration
25th Jun 20197:00 amRNSBoard Change
18th Jun 20197:15 amEQSHardman & Co Research: Oxford BioMedica (OXB): De-leveraging the balance sheet
10th Jun 20192:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.